Education
About Us
Working with TipRanks
Follow Us
GSIE - AI Analysis
Top Page
Goldman Sachs ActiveBeta International Equity ETF (GSIE)
Rating:65Neutral
Price Target:
$44.00
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as ASML Holding NV and Banco Santander, have delivered strong year-to-date performance, supporting overall returns.
Global Diversification
The ETF is geographically diversified across major economies like Japan, the UK, and Germany, reducing reliance on any single country.
Low Expense Ratio
With an expense ratio of 0.25%, this ETF is cost-efficient compared to many actively managed funds.
Negative Factors
Underperforming Holdings
Some top holdings, such as SAP SE, have lagged in performance, which could weigh on the ETF's future returns.
Sector Concentration in Financials
The ETF has significant exposure to the financial sector, which could make it vulnerable to sector-specific downturns.
Mixed Short-Term Performance
The ETF's one-month performance has been slightly negative, indicating potential short-term volatility.
GSIE vs. SPDR S&P 500 ETF (SPY)
AUM4.67B
RegionDeveloped Markets
Expense Ratio0.25%
Beta0.70
IssuerGoldman Sachs
Inception DateNov 06, 2015
Dividend Yield2.75%
Asset ClassEquity
Index TrackedStuttgart Goldman Sachs ActiveBeta Intl.Equity (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume398,388
30 Day Avg. Volume518,723
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.51Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering644
GSIE Summary
The Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an investment fund that focuses on stocks from countries outside the U.S., such as Japan, the UK, and Germany. It uses a strategy to pick companies based on factors like value, quality, and stability. Some well-known companies it includes are Nestlé and ASML Holding. This ETF is a good option for investors looking to diversify their portfolios with international stocks and benefit from potential growth in global markets. However, new investors should know that its performance can be affected by changes in international economies and currency fluctuations.
How much will it cost me?The expense ratio for the Goldman Sachs ActiveBeta International Equity ETF (GSIE) is 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a factor-based strategy rather than traditional stock-picking, keeping costs relatively modest.
What would affect this ETF?The GSIE ETF, with its focus on developed markets outside the U.S., could benefit from economic growth in Europe and Asia, particularly if industries like financials and technology, which have significant weight in the fund, experience expansion. However, it may face challenges from rising interest rates or geopolitical tensions that could negatively impact international markets and sectors like financials and consumer cyclical. Additionally, regulatory changes in key regions or currency fluctuations could influence the ETF's performance.
GSIE Top 10 Holdings
The GSIE ETF leans heavily on developed markets outside the U.S., with a notable concentration in financials and industrials. European giants like ASML Holding and Nestlé are driving steady performance, thanks to their strong financials and growth momentum. Meanwhile, healthcare names like Roche and AstraZeneca are providing a healthy dose of stability, supported by robust pipelines and strategic initiatives. However, SAP has been lagging, weighed down by valuation concerns and mixed technical signals. Overall, the fund’s diversified approach balances rising stars with a few underperformers, offering a broad yet calculated exposure to international equities.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.44% | $66.47M | €358.11B | 50.10% | 78 Outperform | |
| Novartis AG | 0.98% | $45.35M | CHF188.19B | 5.42% | 78 Outperform | |
| SAP SE | 0.96% | $44.43M | €263.59B | 6.04% | 73 Outperform | |
| HSBC Holdings | 0.95% | $43.82M | £184.03B | 50.32% | 79 Outperform | |
| Roche Holding AG | 0.92% | $42.46M | CHF209.75B | 5.79% | 73 Outperform | |
| Royal Bank Of Canada | 0.90% | $41.76M | $205.05B | 20.69% | 75 Outperform | |
| AstraZeneca | 0.83% | $38.10M | £194.50B | 13.62% | 75 Outperform | |
| Advantest | 0.78% | $35.92M | ¥16.30T | 146.12% | 67 Neutral | |
| Banco Santander | 0.76% | $35.02M | €130.00B | 111.73% | 66 Neutral | |
| Nestlé SA | 0.75% | $34.69M | CHF195.74B | 1.23% | 65 Neutral |
GSIE Technical Analysis
Positive
―
Price Trends
41.04
Positive
40.24
Positive
37.94
Positive
Market Momentum
0.14
Negative
51.44
Neutral
44.36
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 41.26, equal to the 50-day MA of 41.04, and equal to the 200-day MA of 37.94, indicating a bullish trend. The MACD of 0.14 indicates Negative momentum. The RSI at 51.44 is Neutral, neither overbought nor oversold. The STOCH value of 44.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSIE.
GSIE Peer Comparison
Comparison Results
Performance Comparison
GSIE
Goldman Sachs ActiveBeta International Equity ETF
41.30
7.86
23.50%
IMTM
iShares MSCI Intl Momentum Factor ETF
―
―
―
LVHI
Legg Mason International Low Volatility High Dividend ETF
―
―
―
INTF
iShares MSCI Intl Multifactor ETF
―
―
―
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
―
―
―
IDMO
Invesco S&P International Developed Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents